DCT

1:25-cv-13865

Board Of Regents Of University Of Texas System v. Alnylam Pharma Inc

General
Filed
12/16/25
Cause of ActionPatent Infringement
SectorBiotech
StatusOpen
Patent Owner
Operating Company
SourcePACER
Nature of Suit830 Patent
Judge
Period
PO Win Rate
12/16/25 - now
--
02/05/25 - 12/16/25
63%
01/10/25 - 02/05/25
18%
MagistrateMark P. Lane
Plaintiff
Defendant
Party